Development of an HPLC method for the quantitation of bisoprolol enantiomers in pharmaceutical products using a teicoplanin chiral stationary phase and fluorescence detection

Journal of Liquid Chromatography and Related Technologies

Volumn 29, Issue 20, 2006, Pages 2901-2914

  Hefnawy, Mohamed M ^a   Sultan, Maha A ^a   Al Shehri, Mona M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Bisoprolol enantiomers; Fluorescence detection; Pharmaceutical products; Teicoplanin chiral stationary phase

Indexed keywords

ELECTROMAGNETIC WAVE EMISSION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHASE TRANSITIONS; ROBUSTNESS (CONTROL SYSTEMS); SEPARATION;

BISOPROLOL ENANTIOMERS; FLUORESCENCE DETECTION; PHARMACEUTICAL PRODUCTS; TEICOPLANIN CHIRAL STATIONARY PHASES;

DRUG PRODUCTS;

ATENOLOL; BISOPROLOL; HYDROCHLOROTHIAZIDE; TEICOPLANIN;

ARTICLE; CHIRAL CHROMATOGRAPHY; DRUG FORMULATION; DRUG STABILITY; ENANTIOMER; FLOW RATE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; QUANTITATIVE ASSAY; ROOM TEMPERATURE;

EID: 33750469370     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826070600978302     Document Type: Article

References (21)

1. Aboul-Enein, H.Y.; Hefnawy, M.M.; Kenichiro, N. Chromatographic method for the analysis of drugs in biological fluids. In Drug Monitoring and Clinical Chemistry; Hempel, G., Ed.; Elsevier: 2004; Chap. 2, 15-75.
2. Zhang, X.; Ouyang, J.; Baeyens, W.R.G.; Zhai, S.; Yang, S.; Huang, G. Enantiomeric separation of β-blockers by HPLC using (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid as chiral stationary phase. J. Pharm. Biomed. Anal. 2003, 31, 1047-1057.
3. Aboul-Enein, H.Y. High performance liquid chromatographic enantioseparation drugs containing multiple chiral centers on polysaccharide-type chiral stationary phases. J. Chromatogr. A 2001, 906, 185-193.
4. Beesley, T.E.; Scott, R.P.W. Chiral Chromatography; John Wiley & Sons: New York, 1998.
5. Aboul-Enein, H.Y.; Ali, I. Optimization strategies for HPLC enantioseparation of racemic drugs using polysaccharides and macrocyclic glycopeptide antibiotic chiral stationary phases. Il Farmaco 2002, 57, 513-529.
6. Ward, T.J.; Farris, A.B. Chiral separations using the macrocyclic antibiotics. J. Chromatogr. A 2001, 906, 73-89.
7. Berthod, A.; Yu, T.; Kullman, J.P.; Armstrong, D.W.; Gasparrini, F.; D'Acquarica, I.; Misiti, D.; Carotti, A. Evaluation of the macrocyclic glycopeptide A-40,926 as a high performance liquid chromatographic chiral selector and comparison with teicoplanin chiral stationary phase. J. Chromatogr. A 2000, 897, 113-129.
8. Armstrong, D.W.; Tang, Y.; Chen, S.; Zhou, Y.; Bagwill, C.; Chen, I.R. Macrocyclic antibiotics as a new class of chiral selectors for liquid chromatography. Anal. Chem. 1994, 66, 1473-1484.
9. Armstrong, D.W.; Zhou, Y. Use of a macrocyclic antibiotic as the chiral selector for enantiomeric separations by TLC. J. Liq. Chromatogr. & Rel. Technol. 1994, 17, 1695-1707.
10. Armstrong, D.W.; Rundlett, K.; Reid, G.G. Use of a macrocyclic antibiotic, rifamycin B, and indirect detection for the resolution of racemic amino-alcohols by CE. Anal. Chem. 1994, 66, 1690-1698.
11. Aboul-Enein, H.Y.; Hefnawy, M.M. Enantioselective determination of arotinolol in human plasma by HPLC using teicoplanin chiral stationary phase. Biomed. Chromatogr. 2003, 17, 453-459.
12. Duret, Ph.; Foucault, A.; Margraff, R. Vancomycin as a chiral selector in centrifugal partition chromatography. J. Liq. Chromatogr. & Rel. Technol. 2000, 23, 295-312.
13. Ekborgott, K.H.; Liu, Y.; Armstrong, D.W. Highly enantioselective HPLC separations using the covalently bonded macrocyclic antibiotic, ristocetin A, chiral stationary phase. Chirality 1998, 10, 434-484.
14. Beesley, T. Chirobiotic Handbook, Advanced Separation Technologies. 2nd Ed.; Whippany, NJ., 1997.
15. Hefnawy, M.M.; Aboul-Enein, H.Y. A validated LC method for the determination of vesamicol enantiomers in human plasma using vancomycin chiral stationary phase and solid phase extraction. J. Pharm. Biomed. Anal. 2004, 35, 535-543.
16. Aboul-Enein, H.Y.; Abou-Basha, L.I. Chirality and drug hazards. In The Impact of Stereochemistry on Drug Development and Use; Wiley: New York, 1997; Chap. 1, 1-19.
17. Schliep, H.J.; Harting, J. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs. J. Cardiovasc. Pharmacol. 1984, 6, 1156-1160.
18. Manalan, A.S.; Besch, H.R.; Watanabe, A.M. Cardiac autonomic receptors. Recent concepts from radiolabeled ligand-binding studies. Circ. Res. 1982, 49, 326-332.
19. Suzuki, T.; Horikiri, Y.; Mizobe, M.; Noda, K. Sensitive determination of bisoprolol in plasma and urine by HPLC using fluorescence detection and application to preliminary study in humans. J. Chromatogr. B. 1993, 619, 267-273.
20. The United State Pharmacopeia, 24th Ed. United State Pharmacopeial Convention: Rockville, MD, 2000; 2150.
21. Fried, K.M.; Koch, P.; Wainer, I.W. Determination of the enantiomers of albuterol in human and canine plasma by enantioselective high performance liquid chromatography on a teicoplanin based chiral stationary phase. Chirality 1998, 10, 484-490.